Connect with CRB at Interphex
Mar 1, 2024
CRB’s team of subject matter experts will be at Interphex this year speaking on various topics. Stop by booth 2719 to connect and learn more.
Don’t miss our team in action:
Panel Discussion: Aseptic Product Manufacturing and Annex 1 Trends
April 16 | 11:15 – 12:00
Christa Myers will be a part of a panel that will discuss existing and new generation parenteral products and containers and how alignment with Annex 1 is going. The data shows that many will not be fully compliant for several years. There are paradigm shifts within different product types that represent a different set of questions that need to be addressed.
Late Breaking: Process Closure: The Next Step in Our Sustainable Evolution
April 16 | 4:00 – 5:00
When evaluating facility designs and contributions to meeting corporate sustainability goals, production equipment, cleanroom environments and supporting utility loads are typically treated as “untouchable.” But conversations around how closed processes could change these “untouchables” are on the rise. Rob Boulanger, PhD, Zach Page-Belknap, and Christa Myers will be a part of the conversation discussing next steps.
Late Breaking: Advancements and Challenges in Antibody-Drug Conjugate Manufacturing
April 17 | 10:00 – 11:00
This presentation offers a comprehensive exploration of the ADC market. Ashley Harp will highlight case studies and industry data to help the audience understand the intricacies associated with this industry and offers a path forward, promoting safer, more sustainable, and potent therapies.
Panel Discussion: Biophorum’s Guidance on Filter Integrity Testing for DS Manufacturing
April 17 | 11:15 – 12:00
The recently revised Annex 1 of the Eudralex includes recommendations for filter integrity testing (FIT) of filters used for sterile filtration of sterile drug products. Manufacturers of low bioburden drug substances are seeking guidance on the appropriate strategy for integrity testing of filters used in bioprocessing. CRB’s Marc Pelletier is a part of a panel that will examine the decision tree used in BioPhorum guidance and consider possible approaches to cases contributed by the participants.
Quick Fires: Evolution of Cell Therapy Manufacturing, Technology, and Facility Planning
April 17 | 3:30 – 3:45
This presentation dives into the transformative journey of autologous cell therapy technologies and the impact on facility planning. JP Bornholdt will talk about what’s happening now – and what’s next for this rapidly evolving market. He will explore the crucial connection between GMP facility design and the safe, effective production of personalized medicine.
More details around the show can be found here. We look forward to seeing you there!